Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Mult Scler ; 30(7): 868-876, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38717089

ABSTRACT

BACKGROUND: There is limited information on interpretation of cognitive changes over time in multiple sclerosis (MS). OBJECTIVE: This study aimed to provide normative data for the assessment of statistically meaningful change in all tests of the Minimal Assessment of Cognitive Function in MS (MACFIMS). METHODS: We applied the reliable change methodology to a healthy Italian cohort, assessed with two alternate versions of the MACFIMS 1 year apart. We calculated confidence intervals of retest score variance using the reliable change index (RCI). Moreover, multivariable linear regression models adjusted for age, sex, education, and baseline score were built to calculate the regression-based change index (RB-CI). RESULTS: Overall, 200 healthy individuals were enrolled. Thresholds for interpreting change in each test were calculated. In the multivariable models, baseline score was associated with retest score in all tests (B from 0.439 to 0.760; p < 0.001). RB-CI can be calculated with data of the multivariable models. CONCLUSION: We provide normative data for reliable cognitive change evaluation for all the tests of the MACFIMS, which includes the Symbol Digit Modalities Test and Brief International Cognitive Assessment in MS, two widely used tools for screening and monitoring cognition in MS. Our findings can significantly improve the interpretation of cognitive changes in MS.


Subject(s)
Cognitive Dysfunction , Multiple Sclerosis , Neuropsychological Tests , Humans , Female , Male , Multiple Sclerosis/complications , Multiple Sclerosis/physiopathology , Adult , Middle Aged , Neuropsychological Tests/standards , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/etiology , Cognitive Dysfunction/physiopathology , Cognition/physiology , Young Adult
2.
Eur Addict Res ; 30(1): 43-51, 2024.
Article in English | MEDLINE | ID: mdl-38151006

ABSTRACT

INTRODUCTION: Chemsex has been defined until now as the use of specific psychoactive substances during sexual activities in men who have sex with men (MSM) contexts to facilitate, enhance, and prolong the experience. Many studies have investigated this phenomenon in specific communities, such as MSM, or have explored the risk of sexually transmitted diseases (STDs). The objective of this study was to investigate the prevalence of chemsex in an Italian group and describe its main characteristics. Additionally, the study aimed to suggest prevention strategies addressing the risks associated with drug use. METHODS: We conducted a cross-sectional observational study. The survey was conducted among 1,828 individuals residing in Italy. Data were collected through a self-completed online survey consisting of 44 questions. RESULTS: 248 people (13.6%) disclosed that they had practiced chemsex, 89 of which (35.9%) were female. Moreover, 13 people (5%) defined themselves as addicted to chemsex; 173 people (69.8%) would like to have more information about the risks related to chemsex, and 79 people (31.8%) would like to talk about this to a professional working in the addiction field. DISCUSSION: The prevalence found in our Italian survey is consistent with findings from other studies. Notably, our survey reveals the presence of chemsex among women. Our results emphasize the necessity for a more comprehensive understanding of chemsex, highlighting the significance of engaging specialized services such as addiction units, STD outpatient clinics, and mental health services. These healthcare facilities can effectively share information and implement risk prevention campaigns focused on chemsex.


Subject(s)
HIV Infections , Sexual and Gender Minorities , Substance-Related Disorders , Male , Humans , Female , Homosexuality, Male/psychology , Cross-Sectional Studies , Prevalence , Sexual Behavior , Substance-Related Disorders/psychology , HIV Infections/complications , HIV Infections/epidemiology
3.
Neurol Sci ; 41(6): 1489-1496, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31953702

ABSTRACT

Cognitive impairment is common in multiple sclerosis (MS), and research has emphasized the crucial role of cognitive assessment in disease monitoring. The minimal neuropsychological assessment of MS (MACFIMS) represents one of the neuropsychological batteries most widely used throughout the world. To date, a complete validation, as well as normative values of an alternative form, is lacking in the Italian population, limiting the use of this tool in longitudinal assessment. A total of 200 healthy subjects (127 females and 73 males) were recruited from the community in 8 Italian cities and were evaluated with the MACFIMS at baseline and reassessed with an alternate form of the same battery after 12 months. Regression-based norms that account for demographic influences on test performance were calculated at each time point (baseline and follow-up). The study provides, for the first time, normative values of two forms of the MACFIMS battery for the Italian population. Data application allows clinicians to monitor the performance of cognitive functions over time and to better understand the efficacy of both pharmacological and non-pharmacological interventions in clinical practice and research.


Subject(s)
Cognitive Dysfunction/diagnosis , Multiple Sclerosis/diagnosis , Neuropsychological Tests/standards , Adolescent , Adult , Aged , Cognitive Dysfunction/etiology , Female , Follow-Up Studies , Humans , Italy , Male , Middle Aged , Multiple Sclerosis/complications , Reference Values , Reproducibility of Results , Young Adult
4.
Neurol Sci ; 41(1): 243, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31713757

ABSTRACT

The above article was published online with an error in author name's affiliation. The Author Claudia Niccolai has changed her affiliation to IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.

5.
Neurol Sci ; 40(8): 1651-1657, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31011932

ABSTRACT

BACKGROUND: The increase in life expectancy of patients with multiple sclerosis (MS) requires a better knowledge of disease features in the older patients group. OBJECTIVE: To describe the prevalence and profile of cognitive impairment (CI) in older patients with MS and perform a comparison with younger patients. METHODS: Patients were consecutively recruited for 6 months. Cognitive performance was assessed through the Brief Repeatable Battery and the Stroop Test. CI was defined as impairment in ≥ 2 cognitive domains. RESULTS: We identified 111 patients older than 55 years (mean age 59.7 years). The prevalence of CI was 77.4%, which was significantly higher than in younger patients (42.8%; p < 0.01). Information processing speed was the most impaired domain (68.8%), followed by verbal learning (49.5%), executive function (47.7%), and visuospatial learning (26.6%). We found no significant differences in the prevalence of impairment in the distinct cognitive domains between older and younger patients with CI. Depression and fatigue were not associated with increased CI among patients in the older age group (p > 0.70). CONCLUSION: There is a remarkably high frequency of CI in older patients with MS. The similar profile of CI between older and younger patients suggests that CI is mostly directly related to MS itself and not to comorbid age-related disorders.


Subject(s)
Aging , Cognitive Dysfunction/epidemiology , Cognitive Dysfunction/etiology , Multiple Sclerosis/complications , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Prevalence , Young Adult
6.
J Neuropsychol ; 12(3): 463-470, 2018 09.
Article in English | MEDLINE | ID: mdl-28891265

ABSTRACT

In this study, we assessed the impact of multiple sclerosis (MS) on bodily self-consciousness (BSC) using the Rubber Hand Illusion. Patients with MS showed a dissociation between body ownership and self-location: they did report an explicit ownership of the rubber hand, but they did not point towards it, showing a defective ability of localizing body parts in space. This evidence indicates that MS may affect selective components of BSC, whose impairment may contribute to, and even worsen, the functional disability of MS.


Subject(s)
Consciousness/physiology , Illusions , Multiple Sclerosis/physiopathology , Multiple Sclerosis/psychology , Visual Perception/physiology , Adult , Female , Humans , Male , Middle Aged , Photic Stimulation , Statistics, Nonparametric
7.
Front Behav Neurosci ; 10: 28, 2016.
Article in English | MEDLINE | ID: mdl-26941630

ABSTRACT

Cognitive rehabilitation in multiple sclerosis (MS) has been reported to induce neuropsychological improvements, but the persistence of these effects has been scarcely investigated over long follow ups. Here, the results of a multicenter randomized clinical trial are reported, in which the efficacy of 15 week domain specific cognitive training was evaluated at 2 years follow up in 41 patients. Included patients were randomly assigned either to domain specific cognitive rehabilitation, or to aspecific psychological intervention. Patients who still resulted to be cognitively impaired at 1 year follow up were resubmitted to the same treatment, whereas the recovered ones were not. Neuropsychological tests and functional scales were administered at 2 years follow up to all the patients. Results revealed that both at 1 and at 2 years follow up more patients in the aspecific group (18/19, 94% and 13/17, 76% respectively) than in the specific group (11/22, 50% and 5/15, 33% respectively) resulted to be cognitively impaired. Furthermore patients belonging to the specific group showed significantly less impaired tests compared with the aspecific group ones (p = 0.02) and a significant amelioration in the majority of the tests. On the contrary patients in the aspecific group did not change. The specific group subjects also perceived a subjective improvement in their cognitive performance, while the aspecific group patients did not. These results showed that short time domain specific cognitive rehabilitation is a useful treatment for patients with MS, shows very long lasting effects, compared to aspecific psychological interventions. Also subjective cognitive amelioration was found in patients submitted to domain specific treatment after 2 years.

8.
Mult Scler ; 22(2): 222-30, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26014600

ABSTRACT

BACKGROUND: Cognitive training has been shown to improve cognitive function and quality of life in multiple sclerosis (MS) patients and is correlated with increased activity in the left dorsolateral prefrontal cortex (DLPFC). OBJECTIVE: This study aims to test whether combining attention training with anodal transcranial direct current stimulation (a-tDCS) over the left DLPFC can improve training efficacy. METHODS: Twenty patients impaired in attention/speed of information processing were randomly assigned to cognitive training during a-tDCS over the left DLPFC or cognitive training during sham tDCS for 10 daily sessions. Neuropsychological evaluations were conducted at baseline, after treatment and six months later. RESULTS: When a-tDCS, rather than sham, was applied during the cognitive training, patients showed a significantly greater improvement in the Symbol Digit Modality Test (SDMT) and Wisconsin Card Sorting Test (WCST) after treatment (p < 0.05) and in the Paced Auditory Serial Addition Test (PASAT) 2" and WCST six months later (p < 0.05). They also had significantly shorter time to reach the most difficult exercise level, compared to sham treatment (6.3 vs. 7.4 sessions; p < 0.05). CONCLUSIONS: These results indicate that a-tDCS on the DLPFC during cognitive training fosters improvements in attention and executive function in MS patients and shortens treatment duration.


Subject(s)
Attention , Cognition Disorders/rehabilitation , Cognition , Multiple Sclerosis, Relapsing-Remitting/rehabilitation , Prefrontal Cortex , Transcranial Direct Current Stimulation/methods , Adult , Cognition Disorders/psychology , Double-Blind Method , Executive Function , Female , Humans , Male , Middle Aged , Multiple Sclerosis, Relapsing-Remitting/psychology , Neurological Rehabilitation , Neuropsychological Tests , Quality of Life , Treatment Outcome
9.
PLoS One ; 10(7): e0131803, 2015.
Article in English | MEDLINE | ID: mdl-26148120

ABSTRACT

Previous studies reported that Multiple Sclerosis (MS) patients treated with natalizumab for one or two years exhibit a significant reduction in relapse rate and in cognitive impairment, but the long term effects on cognitive performance are unknown. This study aimed to evaluate the effects of natalizumab on cognitive impairment in a cohort of 24 consecutive patients with relapsing remitting MS treated for 3 years. The neuropsychological tests, as well as relapse number and EDSS, were assessed at baseline and yearly for three years. The impact on cortical atrophy was also considered in a subgroup of them, and are thus to be considered as preliminary. Results showed a significant reduction in the number of impaired neuropsychological tests after three years, a significant decrease in annualized relapse rate at each time points compared to baseline and a stable EDSS. In the neuropsychological assessment, a significant improvement in memory, attention and executive function test scores was detected. Preliminary MRI data show that, while GM volume did not change at 3 years, a significantly greater parahippocampal and prefrontal gray matter density was noticed, the former correlating with neuropsychological improvement in a memory test. This study showed that therapy with Natalizumab is helpful in improving cognitive performance, and is likely to have a protective role on grey matter, over a three years follow-up.


Subject(s)
Cognition Disorders/drug therapy , Immunologic Factors/therapeutic use , Multiple Sclerosis/drug therapy , Natalizumab/therapeutic use , Adult , Atrophy/drug therapy , Disability Evaluation , Disabled Persons , Disease Progression , Female , Humans , Magnetic Resonance Imaging/methods , Male , Memory/drug effects , Neuropsychological Tests
10.
Neurol Sci ; 35(12): 1895-902, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24998015

ABSTRACT

One of the major problems in clinical neuropsychology is to apply ecological, easily administrable and sensitive tests that can help in the diagnosis of executive functions. In the present paper we present normative values for the D-KEFS sorting test (ST), exploring the ability of reasoning, categorization abilities, problem solving, flexibility of thinking and abstraction. We collected normative data in a group of 181 normal Italian subjects aged between 20 and 69 years old, matched for educational level. Multiple regression analysis was performed to evaluate the potential effects of age, sex and education. Age and education had a significant effect on ST performance. Our study provided normative data for the D-KEFS ST for the adult Italian population, corrections of raw scores for relevant demographic factors, and percentile grids for both baseline data and on re-testing after 9 months of follow-up. These normative Italian values support the use of the D-KEFS ST as a valid instrument for initial neuropsychological evaluation and longitudinal analysis of executive functions in clinical practice and for research purposes.


Subject(s)
Executive Function/physiology , Neuropsychological Tests , Adult , Age Factors , Aged , Female , Humans , Italy , Male , Middle Aged , Reference Values , Regression Analysis , Sex Factors , Young Adult
11.
J Neurol ; 261(9): 1715-25, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24952616

ABSTRACT

We investigated the patterns of regional distribution of focal lesions, white matter (WM) and gray matter (GM) atrophy in patients with cortical (cort) MS in comparison to classical (c) MS patients. Nine cort-MS, nine c-MS and nine age-matched healthy controls (HC) underwent a brain MRI exam, including FLAIR and high-resolution T1-weighted scans. MS patients underwent neurological and neuropsychological assessment. Between-group differences of GM and WM volumes and their correlations with neuropsychological performances were assessed with voxel-based morphometry. FLAIR and T1 lesion probability maps (LPMs) were also obtained. Performance at neuropsychological tests was worse in cort-MS than in c-MS patients. Compared to HC, MS patients had a distributed pattern of GM and WM atrophy. No GM/WM area was more atrophic in c-MS vs cort-MS patients. Compared to c-MS, cort-MS patients experienced GM atrophy of frontal-temporal-parietal areas and cingulate cortex and WM atrophy of the cingulum bundle, bilateral cerebral peduncles, right inferior longitudinal fasciculus and left superior longitudinal fasciculus. FLAIR and T1 LPMs did not differ between c-MS vs cort-MS patients. A higher susceptibility to neurodegenerative processes in key brain regions known to be related to cognitive functions is likely to underlie the clinical manifestations of cort-MS.


Subject(s)
Atrophy/pathology , Gray Matter/pathology , Magnetic Resonance Imaging , Multiple Sclerosis/pathology , White Matter/pathology , Adult , Aged , Case-Control Studies , Female , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Multiple Sclerosis/physiopathology , Multiple Sclerosis/psychology , Neuropsychological Tests
12.
Front Neurol ; 5: 278, 2014.
Article in English | MEDLINE | ID: mdl-25628596

ABSTRACT

BACKGROUND: Specific cognitive rehabilitation in multiple sclerosis (MS) resulted to be effective compared to no treatment. So far the possible role of an aspecific psychological intervention on cognition has not been investigated. OBJECTIVE: The aim of the SMICT RCT was to compare the efficacy of a specific cognitive training with an aspecific psychological intervention in relapsing-remitting MS patients. METHODS: From a sample of 150 patients, with the same disability and immunomodulatory therapy, submitted to neuropsychological examination, 45 impaired in at least one test were included and 41 randomized to have either a specific cognitive training for the impaired function (22) or to an aspecific psychological intervention (19) for 4 months, starting after baseline examination. Neuropsychological tests and functional scales were administered at baseline and 1 year later. RESULTS: After 1 year, the mean number of pathological tests was significantly lower in the specific treatment group, compared to the aspecific group. Memory and attention/speeded information processing functions were mostly improved. Depression and quality of life were not different between groups at follow up. CONCLUSION: Our study demonstrates that an intensive and domain specific cognitive approach results to be more effective than aspecific psychological intervention in patients with MS.

13.
Neurol Sci ; 32(5): 825-32, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21594654

ABSTRACT

The disability, cognitive impairment, fatigue and depression are interacting features in multiple sclerosis (MS), whose relation is still unclear. The objective of this study was to evaluate in a sample of MS patients, the frequency of depressive symptoms, its predicting factors and relation with cognitive impairment, fatigue and disability. 255 consecutive MS patients and 166 healthy subjects were assessed for the presence of depressive symptoms with the Beck Depression Inventory-Fast Screen (BDI-FS). Patients with BDI-FS ≥ 4 were further investigated for the presence of neuropsychological impairment. Depressive symptoms were significantly more frequent and severe in patients than in controls. EDSS score was the only predicting factor of depression (3.5 = threshold EDSS score for depressive symptoms) in patients, whereas neuropsychological impairment was not correlated with BDI-FS and fatigue was found to be significantly correlated with attention, executive function and memory test scores, as well as with BDI-FS score in patients.


Subject(s)
Cognition Disorders/diagnosis , Depression/diagnosis , Depressive Disorder/diagnosis , Multiple Sclerosis/complications , Adult , Attention , Cognition Disorders/complications , Depression/complications , Depressive Disorder/complications , Disability Evaluation , Disabled Persons , Executive Function , Fatigue/complications , Female , Humans , Italy , Male , Memory , Memory Disorders/complications , Memory Disorders/diagnosis , Middle Aged , Neuropsychological Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...